SEP 16, 2020 7:30 AM PDT

Depression, but Not Anxiety, Causes Inflammation and Metabolic Imbalances

WRITTEN BY: Tara Fernandez

Scientists have discovered that depressed individuals show higher levels of inflammation as well as elevated fat concentrations in their bloodstreams. They also demonstrated that people with anxiety don’t have the same biochemical effects, despite the two psychological conditions being regarded as very similar.

More than half of people living with depression have a history of anxiety, and the two conditions have strong parallels in terms of symptoms, risk factors, and therapeutic interventions. However, the physiological effects of these disorders have yet to be fully mapped. Researchers from the Netherlands obtained samples from over 300 patients with depression and another 500 with anxiety, as well as those who have been diagnosed with both conditions and healthy controls. They used a powerful medical imaging technique known as nuclear magnetic resonance to identify links between metabolites in the blood samples and symptoms of either depression or anxiety.

Hilde de Kluiver, one of the study’s senior authors said: “Firstly we found that the depressed group showed evidence of greater inflammation which was not seen in the anxious group. We also found that the depressed group had very different amounts and types of lipids in their blood.”

“For example, depressed people had high levels of triglycerides, but lower levels of omega-3-fatty acids. In contrast, those people who had anxiety disorder had a lipid composition very similar to the healthy control group.”

Depression is a common mental disorder, affecting an estimated 264 million people worldwide. Chronic and severe depression is a serious health condition, reducing the sufferer’s quality of life significantly and can lead to suicidal thoughts. This study shows how depression has a unique and direct impact on the immune system as well as how lipid metabolism is altered in these patients.

This finding is a breakthrough in finding more effective clinical interventions to support patients with depression. "Our group is now planning to test whether depressed people with altered inflammation might respond to treatment with anti-inflammatory drugs", said de Kluiver.

 


Sources: EurekAlert, ECNP Congress.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 14, 2020
Immunology
Happiness Linked to Heart Attack Risk
OCT 14, 2020
Happiness Linked to Heart Attack Risk
Asking patients questions about their personal lives could predict their future risk of a heart attack. A study, publish ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 26, 2020
Immunology
Gearing up for Life: The First 7 Days of the Immune System
OCT 26, 2020
Gearing up for Life: The First 7 Days of the Immune System
The mother’s placenta serves as a shield for the developing fetus inside the womb, protecting it from the constant ...
OCT 29, 2020
Cell & Molecular Biology
How Does the Immune System Handle the Microbiome?
OCT 29, 2020
How Does the Immune System Handle the Microbiome?
The human body plays host to trillions of microbes, and many of them live in our gastrointestinal tract; these microorga ...
NOV 05, 2020
Immunology
Immune cells from recovered COVID-19 patients can help protect immunocompromised individuals against infection
NOV 05, 2020
Immune cells from recovered COVID-19 patients can help protect immunocompromised individuals against infection
Our knowledge of COVID-19 or SARS-CoV-2 is increasing every day, with new research papers published continuously. Resear ...
NOV 04, 2020
Coronavirus
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
NOV 04, 2020
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
COVID-19, the illness caused by the pandemic virus SARS-CoV-2, is known to cause blood clots all over the body in some p ...
Loading Comments...